Article
Characterization of apxlVA, a new RTX determinant of Actinobacillus pleuropneumoniae
1 Aug 1999
Abstract excerpt
A fourth type of RTX determinant was identified in Actinobacillus pleuropneumoniae and was designated apxIVA. When expressed in Escherichia coli, recombinant ApxIVA showed a weak haemolytic activity and co-haemolytic synergy with the sphingomyelinase (beta-toxin) of Staphylococcus aureus. These activities required the presence of an additional gene, ORF1, that is located immediately upstream of apxIVA. The apxIVA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
